PF-2545920
- Product NamePF-2545920
- CAS1292799-56-4
- CBNumberCB32561490
- MFC25H20N4O
- MW392.4525
- MDL NumberMFCD09743765
- MOL File1292799-56-4.mol
- MSDS FileSDS
Chemical Properties
storage temp. | Store at -20°C |
solubility | insoluble in H2O; ≥19.35 mg/mL in DMSO; ≥99.8 mg/mL in EtOH |
form | solid |
FDA UNII | R9Y8EY0G42 |
PF-2545920 Price
Product number | Packaging | Price | Product description | Buy |
---|---|---|---|---|
ApexBio Technology A4325 | 5mg | $189 | PF-2545920 |
Buy |
ApexBio Technology A4325 | 10mM(in 1mL DMSO) | $240 | PF-2545920 |
Buy |
ApexBio Technology A4325 | 10mg | $259 | PF-2545920 |
Buy |
ApexBio Technology A4325 | 50mg | $679 | PF-2545920 |
Buy |
Biorbyt Ltd orb181061 | 100mg | $912.9 | PF-2545920 >98% |
Buy |
PF-2545920 Chemical Properties,Usage,Production
Biological Activity
pf-2545920 is an inhibitor of phosphodiesterase 10a (pde10a) with ic50 value of 0.37nm [1].pde10a is highly expressed in the medium spiny neurons of the striatum and regulates both cgmp and camp. the pde10a inhibitors are believed to regulate cyclic nucleotide signaling in the cortices-triatothalamic circuit. previous inhibitors of pde have potential therapeutic utility but also have potential safety risks due to off-target pde inhibition. thereby pf-2545920 is developed as a more selective inhibitor. pf-2545920 is shown to be efficacious both in vitro and in vivo with improved penetration in cns. it has excellent in vivo efficacy in neurochemical elevation of cyclic nucleotides and in models predictive of antipsychotic activity. administration of pf-2545920 to mice can cause increase in striatal cgmp with the minimal effective dose at about 1mg/kg [1].target
PDE10AReferences
[1] verhoest pr, chapin ds, corman m, fonseca k, harms jf, hou x, marr es, menniti fs, nelson f, o'connor r, pandit j, proulx-lafrance c, schmidt aw, schmidt cj, suiciak ja, liras s. discovery of a novel class of phosphodiesterase 10a inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1h-pyrazol-3-yl)-phenoxymethyl]-quinoline (pf-2545920) for the treatment of schizophrenia. j med chem. 2009 aug 27;52(16):5188-96.Preparation Products And Raw materials
PF-2545920 Supplier
Global(75)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
+undefined-21-51877795 | ivan@atkchemical.com | China | 32480 | 60 | |
86-571-88216897,88216896 13588875226 |
sales@hzclap.com | CHINA | 6313 | 58 | |
+86-29-89586680 +86-15129568250 |
1026@dideu.com | China | 29016 | 58 | |
+1-2135480471 +1-2135480471 |
sales@sarms4muscle.com | China | 10523 | 58 | |
+1-781-999-5354 | support@targetmol.com | United States | 19973 | 58 | |
+1-833-552-7181 | sales@aladdinsci.com | United States | 57511 | 58 | |
0411-62910999 13889544652 |
sales@meilune.com | China | 4647 | 58 | |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 | China | 1494 | 55 | ||
18521735133 18521732826; |
market@aladdin-e.com | China | 25015 | 65 | |
+1 (866) 930-6790 | info@adooq.com | United States | 2784 | 58 |
PF-2545920 Spectrum
1292799-56-4, PF-2545920Related Search
PROMPT×
PROMPT
The What'sApp is temporarily not supported in mainland China
The What'sApp is temporarily not supported in mainland China
Cancel
Determine